EVP 1001-1: Clinical Trials

1 trial of EVP 1001-1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow EVP 1001-1: new trials by email Literature Review of EVP 1001-1 trials Research Report on EVP 1001-1

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury
Manganese-enhanced MRI contrast reagent, Gadolinium-enhanced MRI contrast reagent - ISCHEMIC CARDIOMYOPATHY
Phase 1 / Phase 2CompletedStanford University332015-04-012020-02-17

Conditions studied

Myocardial Infarction (1)

Sponsors

Stanford University (1)

Countries

United States (1)

Top investigators

Phillip C Yang, MD (1)